感染性假体取出后再次植体乳房重建:第二次尝试是否值得?
回顾性研究分析2006年1月至2019年12月因感染取出假体后再次行假体乳房重建的患者,共83例92只乳房。再次重建术后感染率显著高于首次重建(21% vs 9%,p=0.0008),患者报告的乳房满意度和性健康评分也较低。作者认为可合理提供第二次尝试,但需充分告知风险。
要点
- 再次假体乳房重建后感染率为25%(23只乳房),为最常见并发症。
- 再次重建感染率显著高于首次重建(21% vs 9%,p=0.0008)。
- 患者报告的乳房满意度和性健康评分再次重建低于首次重建(p=0.018和p=0.002)。
核心结论
- 因感染取出假体后,为患者提供再次假体乳房重建是合理的。
- 但该人群感染率和取出率更高、患者报告满意度更低,术前讨论和知情同意时需给予合理预期。
研究设计与样本
- 回顾性研究,纳入2006年1月至2019年12月因感染导致假体失败后行第二次假体乳房重建的患者。
- 共6093例假体乳房重建,其中298例(5%)因感染取出假体。
- 83例患者最终接受92只第二次尝试的乳房假体。
- 收集并分析手术结局和患者报告结局(BREAST-Q)。
- 平均随访41±35个月。
主要发现
- 36%的病例发生至少一种术后并发症,感染最常见(23只乳房,25%)。
- 再次重建感染率显著高于首次重建(21% vs 9%,p=0.0008)。
- 患者报告的乳房满意度和性健康评分再次重建低于首次重建(p=0.018和p=0.002)。
- 排除既往放疗和接受假体置换的患者后,成功率为88%。
临床怎么用
- 作者认为因感染取出假体后可合理提供再次假体乳房重建。
- 术前讨论和知情同意时需告知患者感染风险增加和并发症率升高,给予合理预期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infection is a dreaded complication of implant-based breast reconstruction. There is a paucity of literature on the outcomes of a secondary reconstruction after infected implant-based breast reconstruction explantation. METHODS: The authors conducted a retrospective study of patients who underwent a second implant-based breast reconstruction following a failed infected device between January of 2006 and December of 2019. Surgical and patient-reported outcomes (BREAST-Q) were collected and analyzed. RESULTS: A total of 6093 implant-based breast reconstructions were performed during the study period, 298 (5 percent) of which involved device removal because of infection. Eighty-three patients ultimately received 92 second-attempt breast implants. Thirty-six percent of cases developed at least one postoperative complication, with infection [23 breasts (25 percent)] being the most common. Compared with first-attempt implant-based breast reconstruction, we found significantly higher infection rates among second-attempt cases (9 percent and 21 percent, respectively; p = 0.0008). Patient-reported satisfaction with the breast and sexual well-being were lower after second-attempt than after first-attempt implant-based breast reconstruction ( p = 0.018 and p = 0.002, respectively) reported in the literature. Mean follow-up was 41 ± 35 months. If we exclude patients with prior radiation therapy and those who received device exchange, the success rate is 88 percent. CONCLUSIONS: It is reasonable to offer women second-attempt implant-based breast reconstruction after explantation because of infection. However, this patient population has a higher infection and explantation rate and lower patient-reported satisfaction than patients undergoing first-attempt implant-based breast reconstruction. Because of these increased surgical risks and elevated complication rates, patients must be given reasonable expectations during preoperative discussions and when providing informed consent for second-attempt implant-based breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
引用
- Asaad M, Slovacek C, Mitchell D, et al. Implant-Based Breast Reconstruction following Infected Device Explantation: Is a Second Attempt Worth It? Plast Reconstr Surg. 2022. PMID: 35653515. doi:10.1097/PRS.0000000000009289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。